Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HHL | What dos this merger mean for shareholders? | 14/06/17 | 1 | 1.0K | |||
|
|||||||
HHL | Ann: Corporate Governance Statement | 02/06/17 | 0 | 224 | |||
|
|||||||
HHL | Ann: Ceasing to be a substantial holder for BSE | 02/06/17 | 0 | 216 | |||
|
|||||||
HHL | Ann: Change of Director's Interest Notice | 02/06/17 | 0 | 269 | |||
|
|||||||
HHL | Ann: Change in substantial shareholding from BKW | 02/06/17 | 0 | 246 | |||
|
|||||||
HHL | Ann: Change in substantial holding from SOL | 02/06/17 | 0 | 250 | |||
|
|||||||
HHL | News: HHL Hunter Hall International says merger with Pengana Capital approved by HHL shareholders | 01/06/17 | 0 | 284 | |||
|
|||||||
HHL | Ann: Becoming a substantial holder | 01/06/17 | 0 | 229 | |||
|
See All Discussions